Juan Gómez Rivas: Reporting of Unconventional Histologies in Prostate Cancer Remains Inconsistent
Juan Gómez Rivas, Associate Professor at Complutense University of Madrid, shared on X:
“The incidence of unconventional histologies (UHs) in prostate cancer is increasing significantly, rising from 0.7% in 2010 to 19% in 2023 in radical prostatectomy specimens. However, reporting remains inconsistent, even in leading tertiary centers.
Why does it matter? UHs like cribriform, ductal, and intraductal patterns are linked to more aggressive disease and may require different management strategies.
Key Takeaways:
- Biopsies may severely underestimate the true prevalence of UHs.
- There’s a pressing need for standardized reporting.
- Awareness is growing but remains suboptimal across institutions.
This study emphasizes the need to enhance diagnostic accuracy and align pathology practices worldwide.”
Title: Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?
Authors: Giancarlo Marra, Geert J.L.H. van Leenders, Guglielmo David, Marco Oderda, Kirsti Aas, Isabel Heidegger, Fabio Zattoni, Bartosz Małkiewicz, August Sigle, Guglielmo Manti, Juan Gómez Rivas, Igor Tsaur, Timo F.W. Soeterik, Rossella Nicoletti, Erika Palagonia, Agostino Mattei, Luca Afferi, Yannic Raskin, Peter Chiu, Alberto Briganti, Francesco Montorsi, Paolo Gontero, Giorgio Gandaglia
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023